Shareholders' Equity (Tables)

12 Months Ended

Dec. 31, 2011

Shareholders' Equity

Share-Based Activity

	2011		2010		2009
Share-based compensation expense	$	6,178	$	4,869	$	4,068
Fair value of shares vested		7,356		1,647		5,382
Cash received from option exercises		6,872		2,583		201
Tax benefit from option exercises		977		200		34

Schedule Of Changes In Non-Vested Restricted Shares

			Weighted
		Number	Average
		of	Grant
		Shares	Price
Non-vested shares at January 1, 2009		327,751	$	23.83
	Shares granted	162,507		19.34
	Shares vested	(9,666)		22.55
	Shares forfeited	(14,205)		23.59
Non-vested shares at December 31, 2009		466,387	$	22.29
	Shares granted	233,460		21.83
	Shares vested	(8,973)		20.45
	Shares forfeited	(25,965)		22.21
Non-vested shares at December 31, 2010		664,909	$	22.16
	Shares granted	276,869		21.78
	Shares vested	(208,949)		23.11
	Shares forfeited	(417)		24.75
Non-vested shares at December 31, 2011		732,412	$	21.91

Schedule Of Stock Option Activity

					Weighted
					Average
			Weighted		Remaining
		Number	Average		Contractual
		of	Exercise		Term
		Shares	Price		(in years)
Outstanding at January 1, 2009		3,275,803	$	22.23	6.7
	Options exercised with total intrinsic value of $112,000	(14,699)		13.67
	Options terminated	(110,052)		23.73
Outstanding at December 31, 2009		3,151,052	$	22.22	5.0
	Options exercised with total intrinsic value of $511,000	(157,750)		16.38
	Options terminated	(91,313)		23.73
Outstanding at December 31, 2010		2,901,989	$	22.49	4.5
	Options exercised with total intrinsic value of $2,482,000	(374,350)		18.36
	Options terminated	(17,585)		25.42
Outstanding at December 31, 2011 with aggregate intrinsic value of $7,562,000		2,510,054	$	23.09	3.4
Vested or expected to vest at December 31, 2011 with total intrinsic value of $7,562,000		2,510,054	$	23.09	3.4
Exercisable at December 31, 2011 with total intrinsic value of $7,514,000		2,319,844	$	23.02	3.2

Schedule Of Reconciliation Of Numerator And Denominators Of Basic And Diluted Earnings Per Share

						Per
			Earnings		Shares	Share
			(Numerator)		(Denominator)	Amount
For the year ended December 31, 2011:
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (basic)	$	51,199	30,452	$	1.68
	Effect of dilutive securities options and non-vested shares			-	759
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (diluted)	$	51,199	31,211	$	1.64
	Net earnings attributable to AmSurg Corp. per common share (basic)		$	49,997	30,452	$	1.64
	Effect of dilutive securities options and non-vested shares			-	759
	Net earnings attributable to AmSurg Corp. per common share (diluted)		$	49,997	31,211	$	1.60
For the year ended December 31, 2010:
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (basic)	$	51,144	30,255	$	1.69
	Effect of dilutive securities options and non-vested shares			-	434
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (diluted)	$	51,144	30,689	$	1.67
	Net earnings attributable to AmSurg Corp. per common share (basic)		$	49,825	30,255	$	1.65
	Effect of dilutive securities options and non-vested shares			-	434
	Net earnings attributable to AmSurg Corp. per common share (diluted)		$	49,825	30,689	$	1.62
For the year ended December 31, 2009:
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (basic)	$	50,741	30,576	$	1.66
	Effect of dilutive securities options and non-vested shares			-	286
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (diluted)	$	50,741	30,862	$	1.64
	Net earnings attributable to AmSurg Corp. per common share (basic)		$	52,148	30,576	$	1.71
	Effect of dilutive securities options and non-vested shares			-	286
	Net earnings attributable to AmSurg Corp. per common share (diluted)		$	52,148	30,862	$	1.69